Tan Lee Su-Leng · beneficial owner of BioNexus Gene Lab Corp · 67d agono track record yet
Long 338,709 shares of BGLC
338,709 shares · 11.5% of class · 2026-08-13
Schedule 13D: Tan Lee Su-Leng disclosed a stake in BGLC
Tan Lee Su-Leng disclosed a 11.5% stake of 338,709 shares in BioNexus Gene Lab Corp (BGLC) in a Schedule 13D filed 2026-08-14.
At post $1.57Now $1.52-3.2% since postedas of Aug 24, 1:28 PM ET
1d—
3d+1.3%
1w+1.3%
1m+2.5%
3m—
6m—
1y—